Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNasdaq: TSRX
Date7/2013
Raised
Post IPO Valuation
Acquired byCubist Pharmaceuticals
Price$707M
Date7/2013

General Information

Websitetriusrx.com
Twitter@TriusThera
CategoryBioTech
Phone858.452.0370
Employees
Founded2004

Offices

San Diego, USA
6310 Nancy Ridge Drive
Suite 105
San Diego, CA, 92121
USA

People

Chief Financial Officer
President & Chief Executive Officer
Board Member
Board Member
Chairman
Chief Commercial Officer

Funding

TOTAL $30.2M
FUNDING TOTAL $30.2M
Partial Close, 6/2011
$30.2M
DEBT TOTAL $19.2M
Debt, 11/2009
$19.2M

Tags

Trius Therapeutics

Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections.

We have successfully completed two Phase 3 clinical trials for Tedizolid Phosphate (TR-701), formerly torezolid phosphate, in ABSSSI. Tedizolid is an IV and orally administered second generation oxazolidinone, for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). With the continuous increase in bacterial resistance to currently marketed drugs, serious infections are becoming more difficult, if not impossible to treat, and this has led to a clear need for novel therapeutics to treat multi-drug resistant bacterial infections.

Trius is headquartered in San Diego, California. We have built a strong management team with significant development and regulatory experience. Our senior management team consists of nine individuals who collectively have been involved in the development and approval of a significant number of anti-infective drugs.

Recent Milestones

Videos

Screenshots

Trius Therapeutics screenshot
Above: Homepage
Uploaded: 7/31/13

Stock Price

Sources

  1. Cubist Pharmaceuticals to Acquire Trius Therapeutics (businesswire.com) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
Edit This Page
Last Edited 4/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy